L( )-Aminobernsteinsaeure
L( )-Aminobernsteinsaeure Brand names, L( )-Aminobernsteinsaeure Analogs
- (+)-Aspartic acid
- (2S)-Aspartic acid
- (L)-ASPARTIC ACID
- (S)-Aminobutanedioic acid
- (S)-Aspartic acid
- 4-04-00-02998 (Beilstein Handbook Reference)
- AI3-04461
- Acide aspartique [INN-French]
- Acido aspartico [INN-Spanish]
- Acidum asparticum
- Acidum asparticum [INN-Latin]
- Aminosuccinic acid
- Asparagic acid
- Asparagic acid (VAN)
- Asparaginic acid
- Asparaginic acid (VAN)
- Asparaginsaeure [German]
- Aspartate
- Aspartate, L-
- Aspartic Acid [USAN:INN]
- Aspartic acid
- Aspartic acid (VAN)
- Aspartic acid, L-
- Aspatofort
- BRN 1723530
- Butanedioic acid, amino-, (S)-
- CCRIs 6181
- EINECS 200-291-6
- FEMA No. 3565
- H-Asp-OH
- HSDB 1430
- L( )-Aminobernsteinsaeure
- L-(+)-Aspartic acid
- L-2-Aminobutanedioic acid
- L-Aminosuccinic acid
- L-Asparagic acid
- L-Asparaginic acid
- L-Asparaginsaeure
- L-Asparaginsyra
- L-Aspartic acid
- L-Aspartinsaeure
- NSC 3973
L( )-Aminobernsteinsaeure Brand Names Mixture
- No information avaliable
L( )-Aminobernsteinsaeure Chemical_Formula
C4H7N1O4
L( )-Aminobernsteinsaeure RX_link
No information avaliable
L( )-Aminobernsteinsaeure fda sheet
L( )-Aminobernsteinsaeure msds (material safety sheet)
L( )-Aminobernsteinsaeure Synthesis Reference
No information avaliable
L( )-Aminobernsteinsaeure Molecular Weight
133.104 g/mol
L( )-Aminobernsteinsaeure Melting Point
230 oC
L( )-Aminobernsteinsaeure H2O Solubility
4.5 g/l
L( )-Aminobernsteinsaeure State
Solid
L( )-Aminobernsteinsaeure LogP
-0.67 +/- 0.36
L( )-Aminobernsteinsaeure Dosage Forms
Capsules and powder
L( )-Aminobernsteinsaeure Indication
There is no support for the claim that aspartates are exercise performance enhancers, i.e. ergogenic aids.
L( )-Aminobernsteinsaeure Pharmacology
L-aspartate is considered a non-essential amino acid, meaning that, under normal physiological conditions, sufficient amounts of the amino acid are synthesized in the body to meet the body's requirements. L-aspartate is formed by the transamination of the Krebs cycle intermediate oxaloacetate. The amino acid serves as a precursor for synthesis of proteins, oligopeptides, purines, pyrimidines, nucleic acids and L-arginine. L-aspartate is a glycogenic amino acid, and it can also promote energy production via its metabolism in the Krebs cycle. These latter activities were the rationale for the claim that supplemental aspartate has an anti-fatigue effect on skeletal muscle, a claim that was never confirmed.
L( )-Aminobernsteinsaeure Absorption
Absorbed from the small intestine by an active transport process
L( )-Aminobernsteinsaeure side effects and Toxicity
Mild gastrointestinal side effects including diarrhea. LD50 (rat) > 5,000 mg/kg.
L( )-Aminobernsteinsaeure Patient Information
No information avaliable
L( )-Aminobernsteinsaeure Organisms Affected
Humans and other mammals
